Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients

Journal of Pediatrics

Volumn 134, Issue 5, 1999, Pages 589-596

  Quartier, Pierre ^a,b,c   Debré, Marianne ^a,b   De Blic, Jacques ^a,b   De Sauverzac, Rodolphe ^a,b   Sayegh, Natacha ^a,b   Jabado, Nada ^a,b   Haddad, Elie ^a,b   Blanche, Stéphane ^a,b   Casanova, Jean Laurent ^a,b   Smith, C I Edvard ^a,b   Le Deist, Françoise ^a,b   De Saint Basile, Geneviève ^a,b   Fischer, Alain ^a,b  

^a Department of Pediatrics   (France)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

AGAMMAGLOBULINEMIA; ARTICLE; BACTERIAL INFECTION; BRONCHIECTASIS; CHILD; CHILDHOOD DISEASE; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG INDUCED DISEASE; ENTEROVIRUS INFECTION; HUMAN; INFANT; LUNG INSUFFICIENCY; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

EID: 0033511446     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70246-5     Document Type: Article

References (34)

1. 1. Bruton OC. Agammaglobulinemia. Pediatrics 1952;9:722-8.
2. 2. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine 1985;64:145-56.
3. 3. Hermaszewski RA, Webster ADB. Primary hypogammaglobulinemia: a survey of clinical manifestations and complications. Q J Med 1993;86:31-42.
4. 4. Tsukuda S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in X-linked agammaglobulinemia. Cell 1993;72:226-33.
5. 5. Vetrie D, Vorechovski I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein kinases. Nature 1993;361:226-33. [Erratum, Nature 1993;364:362.]
6. 6. Vihinen M, Brooimans RA, Kwan SP, Lehväslaiho H, Litman GW, Ochs HD, et al. BTKbase: XLA-mutation regístry. Immunol Today 1996;17:502-6.
7. 7. Saffran DC, Parolini O, Fitch-Hilgenberg ME, Rawlings DJ, Afar DEH, Witte ON. A point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med 1994;330: 1488-91.
8. 8. Kornfeld SJ, Good RA, Litman GW. Atypical X-linked agammaglobulinemia. N Engl J Med 1994;331:949-50.
9. 9. Bykowsky MJ, Haire RN, Ohta Y, Tang H, Sung SSJ, Veksler ES, et al. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet 1996;58:477-83.
10. 10. Jones A, Bradley L, Alterman L, Tarlow M, Thompson R, Kinnon C, et al. X linked agammaglobulinemia with a "leaky" phenotype. Arch Dis Child 1996;74:548-9.
11. 11. Ochs HD, Smith CIE. X-linked agammaglobulinemia, a clinical and molecular analysis. Medicine 1996;75:287-99.
12. 12. Conley ME, Brown P, Pickard AR, Buckley RH, Miller DS, Raskind WH, et al. Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med 1986;315:564-7.
13. 13. Fearon ER, Winkelstein JA, Civin CI, Pardoll DM, Vogelstein B. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. N Engl J Med 1987;316: 427-31.
14. 14. Conley ME, Puck JM. Carrier detection in typical and atypical X-linked agammaglobulinemia. J Pediatr 1988; 112:688-94.
15. 15. Liese JG, Wintergerst U, Tympner KD, Belohradsky BH. High-vs lowdose immunoglobulin therapy in the long-term outcome of X-linked agammaglobulinemia. Am J Dis Child 1992; 146:335-9.
16. 16. Misbah SA, Spickett GP, Ryba PCJ, Hockaday JM, Kroll JS, Sherwood C, et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol 1992;12:266-70.
17. 17. Robart HA. Enteroviral infections of the central nervous system. Clin Infect Dis 1995;20:971-81.
18. 18. McKinney RF, Katz SL, Wilferi C. Chronic enteroviral infection in agammaglobulinemic patients. Rev Infect Dis 1987;9:334-56.
19. 19. Bernatowska E, Madalinski K. Intravenous immunoglobulin therapy of progressive encephalitis in X-linked hypogammaglobulinemia. Acta Paediatr Scand 1987;76:155-6.
20. 20. Skull S, Kemp A. Treatment of hypogammaglobulinemia with intravenous immunoglobulins, 1973-93. Arch Dis Child 1996;74:527-30.
21. 21. Roifman CM, Gelfand EW. Replacement therapy with high dose intravenous gamma-globulins improves chronic sinopulmonary disease in patients with hypogammaglobulinemia. Pediatr Infect Dis J 1988;7:S92-6.
22. 22. Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 1995;345:365-9.
23. 23. Abrahamsen TG, Sandersen H, Bustnes A. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Pediatrics 1996;98:1127-31.
24. 24. Le Deist F, Thoenes G, Corado J, Lisowska-Grospierre B, Fischer A. Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation. Eur J Immunol 1991;21:1641-7.
25. 25. Vorechovsky I, Vihinen M, de Saint Basile G, Honsova S, Hammarström L, Müller S, et al. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Hum Mol Genet 1995;4:51-8.
26. 26. Parolini O, Fielding Hejtmancik J, Cutler Allen R, Belmont JW, Lassiter GL, Henry MJ, et al. Linkage analysis and physical mapping near the gene for X-linked agammaglobulinemia at Xq22. Genomics 1993;15:342-9.
27. 27. Yel L, Minegishi Y, Coustan-Smith E, Buckley RH, Trübel H, Pachman LM, et al. Mutation in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 1996;335:1486-93.
28. 28. Meffre E, Le Deist F, de Saint Basile G, Deville A, Fougereau M, Fischer A, et al. A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage. J Clin Invest 1996;98:1519-26.
29. 29. Minegishi Y, Coustan-Smith E, Wang YH, Cooper MD, Campana D, Conley ME. Mutations in the human 15/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 1998;187:71-7.
30. 30. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
31. 31. Shapiro GG, Rachelefsky GS. Introduction and definition of sinusitis. J Allergy Clin Immunol 1992;90:417-8.
32. 32. Mease PJ, Ochs HD, Wedgwood RJ. Successful treatment of echovirus meningoencephalitis and myositisfasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N Engl J Med 1981;304:1278-81.
33. 33. Sweinberg SK, Wodell RA, Grodofsky MP, Greene JM, Conley ME. Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia. J Allergy Clin Immunol 1991;88:96-104.
34. 34. Buehring I, Friedrich B, Schaaf J, Schmidt H, Ahrens P, Zielen S. Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies. Clin Exp Immunol 1997;109:468-72.